News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-04-05-2017
Volume12
Issue 4

JRS Pharma Adds Povidone Product Line

Excipient manufacturer adds three tablet binding and disintegration products.

JRS Pharma announced the expansion its line of excipients for tablet binding and disintegration with a Feb. 28, 2017 press statement about a povidone product line that features Vivapharm PVP (povidone) wet binder, Vivapharm PVP/VA 64 (copovidone) tablet binder, and Vivapharm PVPP (crospovidone) to facilitate disintegration performance.

The company reports that the excipients are manufactured in a GMP and ISO 9001 compliant/certified production facility and comply with current compendial requirements in the European, US, and Japanese.

The company reports that it conducts on-site quality checks and final quality control and release in the Analytical Competence Center at the JRS Pharma facilities in Germany.

The company reports that it conducts on-site quality checks and final quality control and release in the Analytical Competence Center at the JRS Pharma facilities in Germany. The products will be warehoused in the JRS PHARMA central logistics center in Germany and the USA, thus enabling ease and speed of delivery.

Source: JRS Pharma

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content